{"id":"W4379376555","doi":"10.1182/bloodadvances.2023010179","title":"Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Astellas Pharma; Daiichi Sankyo Europe; Agios Pharmaceuticals; Celgene; Gilead Sciences; Astex Pharmaceuticals; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Internal medicine; Neutropenia; Medicine; Hazard ratio; Febrile neutropenia; Gastroenterology; Cytarabine; Population; Confidence interval; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002843461,0.001301896,0.00271293,0.0004201166,0.0002579732,0.0008730299,0.0007152069,0.00121268,0.003106584],"category_scores_gemma":[0.001599701,0.0004364109,0.002476042,0.0005567149,0.001075802,0.0006697822,0.0004301596,0.002464321,0.0003883779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007909532,"about_ca_system_score_gemma":0.001160567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009255401,"about_ca_topic_score_gemma":0.002937456,"domain_scores_codex":[0.999108,0.0006452131,0.00002424972,0.0000898097,0.00004369076,0.00008891072],"domain_scores_gemma":[0.9986916,0.0004975292,0.0003147821,0.00009316172,0.00004989628,0.000353064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9645241,0.007557192,0.001724119,0.0005197263,0.001702822,0.00005593438,0.00006271161,0.0007698565,0.003388661,0.0001178134,0.0008504887,0.01872646],"study_design_scores_gemma":[0.9003154,0.09271619,0.003823662,0.00003531345,0.0009087106,0.00006251062,0.00002743147,0.0006605646,0.0004241508,0.0002270232,0.0007811515,0.00001775384],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913174,0.004416237,0.0004911859,0.0005147984,0.0001734152,0.00143227,0.0007011906,0.000067108,0.0008863892],"genre_scores_gemma":[0.9873554,0.004035372,0.0016341,0.001601438,0.0002529836,0.002645171,0.001085757,0.00004050278,0.00134932],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003106584,"threshold_uncertainty_score":0.01503778,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02117231845214376,"score_gpt":0.3626140387781905,"score_spread":0.3414417203260468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}